JP2006505533A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006505533A5 JP2006505533A5 JP2004537065A JP2004537065A JP2006505533A5 JP 2006505533 A5 JP2006505533 A5 JP 2006505533A5 JP 2004537065 A JP2004537065 A JP 2004537065A JP 2004537065 A JP2004537065 A JP 2004537065A JP 2006505533 A5 JP2006505533 A5 JP 2006505533A5
- Authority
- JP
- Japan
- Prior art keywords
- pyrrolidin
- urea
- methyl
- quinolin
- diphenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP0210417 | 2002-09-17 | ||
| PCT/EP2003/010154 WO2004026836A2 (en) | 2002-09-17 | 2003-09-12 | 1-pyridin-4-yl-urea derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006505533A JP2006505533A (ja) | 2006-02-16 |
| JP2006505533A5 true JP2006505533A5 (enExample) | 2006-10-19 |
Family
ID=32010909
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004537065A Abandoned JP2006505533A (ja) | 2002-09-17 | 2003-09-12 | １−ピリジン−４−イル−尿素誘導体 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20060094716A1 (enExample) |
| EP (1) | EP1554249A2 (enExample) |
| JP (1) | JP2006505533A (enExample) |
| KR (1) | KR20050043967A (enExample) |
| CN (1) | CN1681789A (enExample) |
| AU (1) | AU2003270186A1 (enExample) |
| BR (1) | BR0314353A (enExample) |
| CA (1) | CA2496624A1 (enExample) |
| MX (1) | MXPA05002839A (enExample) |
| NO (1) | NO20050932L (enExample) |
| RU (1) | RU2005111589A (enExample) |
| WO (1) | WO2004026836A2 (enExample) |
| ZA (1) | ZA200502009B (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GEP20115290B (en) | 2002-11-27 | 2011-09-26 | Incyte Corp | 3-aminopyrrolidine derivatives as modulators of chemokine receptors |
| AU2004212985B2 (en) | 2003-02-20 | 2010-10-14 | Encysive Pharmaceuticals Inc. | Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonists |
| US7288538B2 (en) | 2003-02-20 | 2007-10-30 | Encysive Pharmaceuticals, Inc. | Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonists |
| US7320989B2 (en) | 2003-02-28 | 2008-01-22 | Encysive Pharmaceuticals, Inc. | Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists |
| WO2004078114A2 (en) | 2003-02-28 | 2004-09-16 | Encysive Pharmaceuticals Inc. | Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-ii receptor antagonists. |
| ATE440835T1 (de) | 2003-03-06 | 2009-09-15 | Glaxo Group Ltd | Heterozyklische harnstoff-derivate für die behandlung von schmerzen. |
| WO2004078744A2 (en) * | 2003-03-07 | 2004-09-16 | Glaxo Group Limited | Urea derivatives and their use as vanilloid receptor antagonists in the treatment of pain |
| GB0305426D0 (en) | 2003-03-08 | 2003-04-16 | Glaxo Group Ltd | Novel compounds |
| EP1608319A4 (en) | 2003-04-03 | 2007-02-28 | Univ California | IMPROVED HEMMER FOR SOLUBLE EPOXY HYDROLASE |
| CN1856305B (zh) * | 2003-09-26 | 2010-04-28 | 埃科特莱茵药品有限公司 | 用作尾加压素ⅱ拮抗剂的吡啶衍生物 |
| CA2559665A1 (en) | 2004-03-16 | 2005-09-29 | The Regents Of The University Of California | Reducing nephropathy with inhibitors of soluble epoxide hydrolase and epoxyeicosanoids |
| CN101039930B (zh) * | 2004-10-12 | 2010-08-11 | 埃科特莱茵药品有限公司 | 作为结晶硫酸盐的1-[2-(4-甲苯基-4-羟基-哌啶-1-基)-乙基]-3-(2-甲基-喹啉-4-基)-脲 |
| ZA200703613B (en) | 2004-10-20 | 2009-05-27 | Univ California | Improved inhibitors for the soluble epoxide hydrolase |
| EP1928821B1 (en) | 2005-09-21 | 2009-01-07 | Pfizer Limited | Carboxamide derivatives as muscarinic receptor antagonists |
| TW200808723A (en) | 2006-03-13 | 2008-02-16 | Univ California | Conformationally restricted urea inhibitors of soluble epoxide hydrolase |
| US8258301B2 (en) * | 2007-05-15 | 2012-09-04 | Boehringer Ingelheim International Gmbh | Urotensin II receptor antagonists |
| TWI441830B (zh) * | 2008-06-03 | 2014-06-21 | Actelion Pharmaceuticals Ltd | 〔４－（１－胺基－乙基）－環己基〕－甲基胺及〔６－（１－胺基－乙基）－四氫－吡喃－３－基〕－甲基－胺衍生物 |
| US9296693B2 (en) | 2010-01-29 | 2016-03-29 | The Regents Of The University Of California | Acyl piperidine inhibitors of soluble epoxide hydrolase |
| MX2012010666A (es) * | 2010-03-31 | 2012-10-05 | Actelion Pharmaceuticals Ltd | Derivados de isoquinolin-3-ilurea antibacterianos. |
| CN105622431A (zh) * | 2011-01-28 | 2016-06-01 | 肯塔基大学研究基金会 | 茋类似物和治疗癌症的方法 |
| RU2017129757A (ru) | 2015-01-23 | 2019-02-25 | ДжиВиКей БИОСАЕНСЕЗ ПРАЙВИТ ЛИМИТЕД | ИНГИБИТОРЫ TrkA КИНАЗЫ |
| CN107056673B (zh) * | 2016-09-09 | 2019-10-29 | 南京工业大学 | 一种3,4-二芳基马来酰亚胺衍生物及其制备方法与应用 |
| CN106432039B (zh) * | 2016-09-27 | 2019-02-22 | 南京工业大学 | 3,4-二芳基马来酰亚胺衍生物及其制备方法与应用 |
| CN110862398B (zh) * | 2018-08-27 | 2021-04-06 | 北京赛特明强医药科技有限公司 | 脲取代的芳环连二噁烷并喹唑啉或喹啉类化合物、组合物及其应用 |
| FI4097099T3 (fi) | 2020-02-07 | 2024-07-30 | Gasherbrum Bio Inc | Heterosyklisiä glp-1-agonisteja |
| IL322686A (en) | 2023-02-16 | 2025-10-01 | Gasherbrum Bio Inc | Heterocyclic glp-1 agonists |
| CN119219821A (zh) * | 2024-12-03 | 2024-12-31 | 江苏金杉新材料有限公司 | 用于湿法冶金的苯乙烯系阴离子树脂及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR016817A1 (es) * | 1997-08-14 | 2001-08-01 | Smithkline Beecham Plc | Derivados de fenilurea o feniltiourea, procedimiento para su preparacion, coleccion de compuestos, compuestos intermediarios, composicion farmaceutica,metodo de tratamiento y uso de dichos compuestos para la manufactura de un medicamento |
| AUPP003197A0 (en) * | 1997-09-03 | 1997-11-20 | Fujisawa Pharmaceutical Co., Ltd. | New heterocyclic compounds |
| AU2804400A (en) * | 1999-02-12 | 2000-08-29 | Smithkline Beecham Plc | Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists |
| US6815451B2 (en) * | 2001-03-27 | 2004-11-09 | Actelion Pharmaceuticals Ltd. | 1,2,3,4-Tetrahydroisoquinolines derivatives as urotensin II receptor antagonists |
| CA2473892C (en) * | 2001-12-04 | 2010-09-21 | Actelion Pharmaceuticals Ltd | Novel quinoline derivatives |
-
2003
- 2003-09-12 KR KR1020057004455A patent/KR20050043967A/ko not_active Withdrawn
- 2003-09-12 AU AU2003270186A patent/AU2003270186A1/en not_active Abandoned
- 2003-09-12 US US10/528,043 patent/US20060094716A1/en not_active Abandoned
- 2003-09-12 RU RU2005111589/04A patent/RU2005111589A/ru not_active Application Discontinuation
- 2003-09-12 MX MXPA05002839A patent/MXPA05002839A/es unknown
- 2003-09-12 EP EP03750534A patent/EP1554249A2/en not_active Withdrawn
- 2003-09-12 CN CNA038219646A patent/CN1681789A/zh active Pending
- 2003-09-12 CA CA002496624A patent/CA2496624A1/en not_active Abandoned
- 2003-09-12 JP JP2004537065A patent/JP2006505533A/ja not_active Abandoned
- 2003-09-12 WO PCT/EP2003/010154 patent/WO2004026836A2/en not_active Ceased
- 2003-09-12 BR BR0314353-8A patent/BR0314353A/pt not_active IP Right Cessation
-
2005
- 2005-02-21 NO NO20050932A patent/NO20050932L/no not_active Application Discontinuation
- 2005-03-09 ZA ZA200502009A patent/ZA200502009B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006505533A5 (enExample) | ||
| RU2005111589A (ru) | Производные 1-пиридин-4-илмочевины | |
| EP1960370B1 (de) | Pyridiazinonderivate zur behandlung von tumoren | |
| CA2473892A1 (en) | Novel quinoline derivatives | |
| EP2150539B1 (de) | Pyridazinonderivate | |
| US9452997B2 (en) | Piperidine and piperazine derivatives as autotaxin inhibitors | |
| US8680139B2 (en) | Anti-neoplastic compounds, compositions and methods | |
| US8637518B2 (en) | Pyridazinone derivatives | |
| EP2220070B1 (de) | 2-benzylpyridazinonderivate als met-kinasehemmer | |
| EP2152370B1 (de) | Arylether-pyridazinonderivate | |
| CN1323079C (zh) | 血管紧张肽原酶抑制剂 | |
| KR101049074B1 (ko) | 치환된 1,4-디-피페리딘-4-일-피페라진 유도체 및 뉴로키닌길항제로서의 그의 용도 | |
| EP2513057B1 (de) | Inhibitoren der sphingosinkinase | |
| JP2004529132A5 (enExample) | ||
| TW200403058A (en) | Heterocyclo inhibitors of potassium channel function | |
| EP2049531A2 (de) | 2-(heterocyclylbenzyl)-pyridazinonderivate | |
| DE102007032507A1 (de) | Pyridazinonderivate | |
| DE102007038957A1 (de) | 6-Thioxo-pyridazinderivate | |
| DK2621916T3 (en) | Benzazole derivatives as histamine H 4 receptor ligands | |
| JP2011505388A (ja) | レニン阻害剤 | |
| EP2285811A1 (de) | 3-(3-pyrimidin-2-yl-benzyl)-ý1,2,4¨triazoloý4,3-b¨pyridazin-derivative als met-kinase inhibitoren | |
| JP2007506692A5 (enExample) | ||
| CA2545092A1 (en) | Quinolonecarboxylic acid compounds having 5-ht4 receptor agonistic activity | |
| RU2006113948A (ru) | Производные пиридина и их применение в качестве антагонистов уротензина ii | |
| EP2958901B1 (de) | 2-amino-3,4-dihydro-chinazolin derivate und ihre verwendung als cathepsin d inhibitoren |